Trial Profile
A phase 1 study of NI-0801 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs NI 0801 (Primary)
- Indications Allergic contact dermatitis; Primary biliary cirrhosis
- Focus Adverse reactions
- Sponsors Light Chain Bioscience; NovImmune SA
- 17 Jul 2009 New trial record.
- 13 Jul 2009 Results have been announced in a NovImmune media release.